Healthcare provider profile · identity verified

Harvey D. Shipkovitz, M.D.

Family Practice · PITTSBURGH, PA · NPI 1841379286

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	448	28
Omeprazole	Omeprazole	185	24
Amlodipine Besylate	Amlodipine Besylate	180	28
Gabapentin	Gabapentin	176	21
Quetiapine Fumarate	Quetiapine Fumarate	168	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	165	suppressed
Atorvastatin Calcium	Atorvastatin Calcium	160	27
Risperidone	Risperidone	157	13
Simvastatin	Simvastatin	155	20
Trazodone Hcl	Trazodone Hcl	152	15
Metformin Hcl	Metformin Hcl	133	16
Levothyroxine Sodium	Levothyroxine Sodium	130	16
Furosemide	Furosemide	117	20
Lisinopril	Lisinopril	112	16
Lorazepam	Lorazepam	111	14
Ibuprofen	Ibuprofen	96	21
Potassium Chloride	Potassium Chloride	95	17
Sertraline Hcl	Sertraline Hcl	80	suppressed
Bumetanide	Bumetanide	78	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	74	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	74	13
Citalopram Hbr	Citalopram Hydrobromide	73	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	71	14
Clopidogrel	Clopidogrel Bisulfate	70	suppressed
Atenolol	Atenolol	67	suppressed
Clonazepam	Clonazepam	64	12
Metoprolol Tartrate	Metoprolol Tartrate	63	11
Eliquis	Apixaban	60	suppressed
Glipizide Er	Glipizide	57	suppressed
Paroxetine Hcl	Paroxetine Hcl	55	suppressed
Olanzapine	Olanzapine	54	suppressed
Enalapril Maleate	Enalapril Maleate	52	suppressed
Finasteride	Finasteride	52	suppressed
Paliperidone Er	Paliperidone	52	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	48	suppressed
Glimepiride	Glimepiride	47	suppressed
Breo Ellipta	Fluticasone/Vilanterol	46	suppressed
Divalproex Sodium	Divalproex Sodium	44	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	13
Clonidine Hcl	Clonidine Hcl	41	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	41	suppressed
Losartan Potassium	Losartan Potassium	41	suppressed
Metoprolol Succinate	Metoprolol Succinate	41	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	41	suppressed
Unifine Safecontrol Pen Needle	Pen Needle,dual Safety,diabetc	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Benztropine Mesylate	Benztropine Mesylate	38	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	36	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	suppressed
Carvedilol	Carvedilol	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Loperamide	Loperamide Hcl	33	26
Azithromycin	Azithromycin	32	23
Divalproex Sodium Er	Divalproex Sodium	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Famotidine	Famotidine	28	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	28	suppressed
Tramadol Hcl	Tramadol Hcl	27	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Primidone	Primidone	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Klor-Con M10	Potassium Chloride	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Perphenazine	Perphenazine	20	suppressed
Amoxicillin	Amoxicillin	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Naproxen	Naproxen	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Carbamazepine	Carbamazepine	15	suppressed
Cephalexin	Cephalexin	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Ibu	Ibuprofen	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Unifine Pentips Plus	Pen Needle, Diabetic	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	13	suppressed
Haloperidol	Haloperidol	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Temazepam	Temazepam	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Meloxicam	Meloxicam	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error